Gray Matter Differences in Adolescent Psychiatric Inpatients: A Machine Learning Study of Bipolar Disorder and Other Psychopathologies
Brain and Behavior · 2025
DOI: 10.1002/brb3.70589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Renata Rozovsky und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Bipolar Disorder, Gray Matter, Brain, Mental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
Background
Bipolar disorder (BD) is among the psychiatric disorders most prone to misdiagnosis, with both false positives and false negatives resulting in treatment delay. We employed a whole‐brain machine learning approach focusing on gray matter volumes (GMVs) to contribute to defining objective biomarkers of BD and discriminating it from other forms of psychopathology, including subthreshold manic presentations without a BD Type I/II diagnosis.
Methods
Five support vector machine (SVM) models were used to detect differences in GMVs between inpatient adolescents aged 13–17 with BD‐I/II ( n = 34), other specified BD (OSB) ( n = 106), other non‐bipolar psychopathology (OP) ( n = 52), and healthy controls (HC) ( n = 27). We examined the most discriminative GMVs and tested their associations with clinical symptoms.
Results
Whole‐brain classifiers in the model BD‐I/II versus OSB achieved total accuracy of 79%, (AUC = 0.70, p = 0.002); BD versus OP 66%, (AUC = 0.61, p = 0.014); BD versus HC 66%, (AUC = 0.67, p = 0.011); OSB versus HC 77%, (AUC = 0.61, p = 0.01); OP versus HC 68%, (AUC = 0.70, p = 0.001). The most discriminative GMVs that contributed to the classification were in areas associated with movement, sensory processing, and cognitive control. Correlations between these GMVs and self‐reported mania, negative affect, or anxiety were observed in all inpatient groups.
Conclusions
These findings indicate that pattern recognition models focusing on GMVs in regions associated with movement, sensory processing, and cognitive control can effectively distinguish well‐characterized BD‐I/II from other forms of psychopathology, including other specified BD, in a pediatric population. These results may contribute to enhancing diagnostic accuracy and guiding earlier, more targeted interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Western Psychiatric Hospital, University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Renata Rozovsky
Förderung
- NIMH NIH HHS
- National Institute of Mental Health
Zitieren
APA
Rozovsky, R., Wolfe, M., Abdul-Waalee, H., Chobany, M., Malgireddy, G., Hart, J. A., Lepore, B., Vahedifard, F., Phillips, M. L., Birmaher, B., Skeba, A., Diler, R. S., & Bertocci, M. A. (2025). Gray Matter Differences in Adolescent Psychiatric Inpatients: A Machine Learning Study of Bipolar Disorder and Other Psychopathologies. Brain and Behavior. https://doi.org/10.1002/brb3.70589
Vancouver
Rozovsky R, Wolfe M, Abdul-Waalee H, Chobany M, Malgireddy G, Hart JA, et al. Gray Matter Differences in Adolescent Psychiatric Inpatients: A Machine Learning Study of Bipolar Disorder and Other Psychopathologies. Brain and Behavior. 2025. doi:10.1002/brb3.70589
BibTeX
@article{Rozovsky2025,
author = {Rozovsky, Renata and Wolfe, Maria and Abdul-Waalee, Halimah and Chobany, Mariah and Malgireddy, Greeshma and Hart, Jonathan A and Lepore, Brianna and Vahedifard, Farzan and Phillips, Mary L and Birmaher, Boris and Skeba, Alex and Diler, Rasim S and Bertocci, Michele A},
title = {Gray Matter Differences in Adolescent Psychiatric Inpatients: A Machine Learning Study of Bipolar Disorder and Other Psychopathologies},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70589}
}
EUVIMED